D. Bodian, Histopathologic basis of clinical findings in poliomyelitis, The American Journal of Medicine, vol.6, issue.5, pp.563-578, 1949.

T. Couderc, C. Christodoulou, H. Kopecka, S. Marsden, L. F. Taffs et al., Molecular Pathogenesis of Neural Lesions Induced by Poliovirus Type 1, Journal of General Virology, vol.70, issue.11, pp.2907-2918, 1989.

J. H. Wikel, C. J. Paget, D. C. Delong, J. D. Nelson, C. Y. Wu et al., Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication, Journal of Medicinal Chemistry, vol.23, issue.4, pp.368-372, 1980.

H. Ishitsuka, C. Ohsawa, T. Ohiwa, I. Umeda, and Y. Suhara, Antipicornavirus flavone Ro 09-0179., Antimicrobial Agents and Chemotherapy, vol.22, issue.4, pp.611-616, 1982.

A. S. Galabov, L. Nikolaeva, and S. Philipov, Aporphinoid alkaloid glaucinone: A selective inhibitor of poliovirus replication, Antiviral Research, vol.26, issue.3, p.A347, 1995.

M. Arita, T. Wakita, and H. Shimizu, Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity, Journal of General Virology, vol.89, issue.10, pp.2518-2530, 2008.

A. M. De-palma, H. J. Thibaut, L. Van-der-linden, K. Lanke, W. Heggermont et al., Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307, Antimicrobial Agents and Chemotherapy, vol.53, issue.5, pp.1850-1857, 2009.

M. Arita, H. Kojima, T. Nagano, T. Okabe, T. Wakita et al., Phosphatidylinositol 4-Kinase III Beta Is a Target of Enviroxime-Like Compounds for Antipoliovirus Activity, Journal of Virology, vol.85, issue.5, pp.2364-2372, 2010.

L. Delang, J. Paeshuyse, and J. Neyts, The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication, Biochemical Pharmacology, vol.84, issue.11, pp.1400-1408, 2012.

A. M. Macleod, D. R. Mitchell, N. J. Palmer, H. Van-de-poël, K. Conrath et al., Identification of a Series of Compounds with Potent Antiviral Activity for the Treatment of Enterovirus Infections, ACS Medicinal Chemistry Letters, vol.4, issue.7, pp.585-589, 2013.

A. M. Macleod, D. R. Mitchell, N. J. Palmer, H. Van-de-poël, K. Conrath et al., Identification of a Series of Compounds with Potent Antiviral Activity for the Treatment of Enterovirus Infections, ACS Medicinal Chemistry Letters, vol.4, issue.7, pp.585-589, 2013.

M. Arita, H. Kojima, T. Nagano, T. Okabe, T. Wakita et al., Oxysterol-Binding Protein Family I Is the Target of Minor Enviroxime-Like Compounds, Journal of Virology, vol.87, issue.8, pp.4252-4260, 2013.

J. R. Strating, L. Van der linden, L. Albulescu, J. Bigay, M. Arita et al., Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein, Cell Reports, vol.10, issue.4, pp.600-615, 2015.

M. Arita, G. Dobrikov, G. Pürstinger, and A. S. Galabov, Allosteric Regulation of Phosphatidylinositol 4-Kinase III Beta by an Antipicornavirus Compound MDL-860, ACS Infectious Diseases, vol.3, issue.8, pp.585-594, 2017.

N. Y. Hsu, O. Ilnytska, G. Belov, M. Santiana, Y. Chen et al., Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication, Cell, vol.141, issue.5, pp.799-811, 2010.

Z. A. Knight, B. Gonzalez, M. E. Feldman, E. R. Zunder, D. D. Goldenberg et al., A Pharmacological Map of the PI3-K Family Defines a Role for p110? in Insulin Signaling, Cell, vol.125, issue.4, pp.733-747, 2006.

T. Balla, Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation, Physiological Reviews, vol.93, issue.3, pp.1019-1137, 2013.

L. Albulescu, J. Bigay, B. Biswas, M. Weber-boyvat, C. M. Dorobantu et al., Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307, Antiviral Research, vol.140, pp.37-44, 2017.

B. Mesmin, J. Bigay, J. Moser von filseck, S. Lacas-gervais, G. Drin et al., A Four-Step Cycle Driven by PI(4)P Hydrolysis Directs Sterol/PI(4)P Exchange by the ER-Golgi Tether OSBP, Cell, vol.155, issue.4, pp.830-843, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02109031

V. M. Olkkonen and S. Li, Oxysterol-binding proteins: Sterol and phosphoinositide sensors coordinating transport, signaling and metabolism, Progress in Lipid Research, vol.52, issue.4, pp.529-538, 2013.

N. D. Ridgway and K. Zhao, Cholesterol transfer at endosomal-organelle membrane contact sites, Current Opinion in Lipidology, vol.29, issue.3, pp.212-217, 2018.

B. Antonny, J. Bigay, and B. Mesmin, The Oxysterol-Binding Protein Cycle: Burning Off PI(4)P to Transport Cholesterol, Annual Review of Biochemistry, vol.87, issue.1, pp.809-837, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02109453

B. A. Heinz and L. M. Vance, The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus., Journal of virology, vol.69, issue.7, pp.4189-4197, 1995.

P. L. Rodriguez and L. Carrasco, Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol., Journal of Virology, vol.66, issue.4, pp.1971-1976, 1992.

M. Arita, Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure, Microbiology and Immunology, vol.58, issue.4, pp.239-256, 2014.

M. Arita, Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III ? Inhibitor, ACS Infectious Diseases, vol.2, pp.140-148, 2016.

C. E. Melia, Escaping Host Factor PI4KB Inhibition: Enterovirus Genomic RNA Replication in the Absence of Replication Organelles, Cell reports, vol.21, pp.587-599, 2017.

H. Lyoo, C. M. Dorobantu, H. M. Van-der-schaar, and F. Van-kuppeveld,

S. Berryman, K. Moffat, C. Harak, V. Lohmann, and T. Jackson, Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases, J. Gen. Virol, vol.97, pp.1841-1852, 2016.

M. Arita, H. Shimizu, and T. Miyamura, Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity, J. Gen. Virol, vol.85, pp.1933-1944, 2004.

B. A. Heinz and L. M. Vance, Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses., Journal of virology, vol.70, issue.7, pp.4854-4857, 1996.

X. Xiao, Enterovirus 3A facilitates viral replication by promoting PI4KB-ACBD3 interaction, J. Virol, vol.91, pp.791-00717, 2017.

G. A. Belov, Complex dynamic development of poliovirus membranous replication complexes, J. Virol, vol.86, pp.302-312, 2012.

B. Mesmin, Sterol transfer, PI4P consumption, and control of membrane lipid order by endogenous OSBP, EMBO J, vol.36, pp.3156-3174, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01617401

M. Ida-hosonuma, T. Iwasaki, T. Yoshikawa, N. Nagata, Y. Sato et al., The Alpha/Beta Interferon Response Controls Tissue Tropism and Pathogenicity of Poliovirus, Journal of Virology, vol.79, issue.7, pp.4460-4469, 2005.

Y. Xiao, Poliovirus intrahost evolution is required to overcome tissue-specific innate immune responses, Nat. Commun, vol.8, p.375, 2017.

E. G. Viktorova, J. A. Nchoutmboube, L. A. Ford-siltz, E. Iverson, and G. A. Belov, Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles, PLoS Pathog, vol.14, p.1007280, 2018.

N. E. Sanjana, O. Shalem, and F. Zhang, Improved vectors and genome-wide libraries for CRISPR screening, Nat Methods, vol.11, pp.783-784, 2014.

M. Arita, A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region, J. Virol, vol.79, pp.12650-12657, 2005.

L. Kamentsky, Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software, Bioinformatics, vol.27, pp.1179-1180, 2011.